echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: Safety analysis of Covid-19 mRNA vaccine

    NEJM: Safety analysis of Covid-19 mRNA vaccine

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pre-approved trials have shown that a messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has good safety, but these trials are limited by scale and patient mix
    .


    The safety of the BNT162b2mRNA vaccine in terms of a wider range of potential adverse events needs to be evaluated



    Recently, a research article was published in the top medical journal NEJM.


    Researchers used data from Israel's largest healthcare organization to evaluate the safety of the BNT162b2mRNA vaccine



    Diagnose infection

    In the vaccination analysis, the vaccinated group and the control group each contained 884,828 subjects
    .


    Vaccination and myocarditis (hazard ratio of 3.


    Arrhythmia thrombosis In this nationwide mass vaccination study, the BNT162b2 vaccine was not associated with the increased risk of most adverse events assessed


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.